Evaluating the treatment of hypertension in diabetes mellitus: A need for better control?

Journal of Evaluation in Clinical Practice

Volumn 10, Issue 1, 2004, Pages 107-116

  Sequeira, Reginald P ^a   Jassim Al Khaja, Khalid A ^a   Damanhori, Awatif H H ^b  

^a ARABIAN GULF UNIVERSITY   (Bahrain)

^b Primary Care   (Bahrain)

Author keywords

Blood pressure control; Diabetic hypertension; Primary care; Therapeutic audit

Indexed keywords

ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CAPTOPRIL; CHLORTALIDONE; CLOPAMIDE; CREATININE; DIHYDROERGOCRISTINE; DILTIAZEM; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; ENALAPRIL; GLIBENCLAMIDE; GLICLAZIDE; GLYCOSYLATED HEMOGLOBIN; HYDRALAZINE; HYDROCHLOROTHIAZIDE; INDAPAMIDE; LISINOPRIL; METFORMIN; METHYLDOPA; NIFEDIPINE; PERINDOPRIL; PROPRANOLOL; RESERPINE; TRIACYLGLYCEROL; UNINDEXED DRUG; UREA; URIC ACID; VERAPAMIL;

ADULT; AGED; ARTICLE; BAHRAIN; BLOOD PRESSURE REGULATION; DIABETES MELLITUS; ELECTROLYTE BLOOD LEVEL; FEMALE; GLUCOSE BLOOD LEVEL; HIGH RISK PATIENT; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MEDICAL AUDIT; MEDICAL RECORD; PRACTICE GUIDELINE; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; RISK FACTOR; SYSTOLIC HYPERTENSION;

ANTIHYPERTENSIVE AGENTS; BAHRAIN; BLOOD PRESSURE; DIABETES COMPLICATIONS; DIABETES MELLITUS; FEMALE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; PRIMARY HEALTH CARE;

EID: 1242307964     PISSN: 13561294     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2753.2003.00404.x     Document Type: Article

References (54)

1. ADA (American Diabetes Association) (2002) Diabetic nephropathy. Diabetic Care 25 (Suppl. 1), S85-S89.
2. Al Khaja K.A.J., Sequeira R.P. & Mathur V.S. (2000) Patterns of utilization of antihypertensive drug combinations in Bahrain: do they conform with international guidelines? International Journal of Clinical Pharmacology and Therapeutics 38, 568-580.
3. Al Khaja K.A.J., Sequeira R.P. & Mathur V.S. (2001) Prescribing patterns and therapeutic implications for diabetic hypertension. Annals of Pharmacotherapy 35, 1350-1359.
4. Alderman M.H., Furberg C.D., Kostis J.B., Laragh J.H., Psaty B.M., Ruilope L.M., Volpe M. & Jackson R. (2002) Hypertension guidelines: criteria that might make them more useful. American Journal of Hypertension 15, 917-923.
5. Bakris G.L., Williams M., Dworkin L., Elliott W.J., Epstein M., Toto R., Tuttle K., Douglas J., Hsueh W. & Sowers J. (2000) Preserving renal function in adults with hypertension and diabetes: a consensus approach. American Journal of Kidney Diseases 36, 646-661.
6. Berlowitz D.R., Asch A.S., Hickey E.C., Friedman R.H., Glickman M., Kaden M. & Miskowitz M.A. (1998) Inadequate management of blood pressure in hypertensive population. New England Journal of Medicine 339,1957-1963.
7. Black H.R. (2002) Risk stratification of older patients. American Journal of Hypertension 15, 77S-81S.
8. Bradley C. (1992) Uncomfortable prescribing decisions: critical incident study. British Medical Journal 304, 1294-1296.
9. Brenner B.M., Cooper M.E., de Zeeuw D., Keane W.F., Mitch W.E., Parving H.H., Remuzzi G., Snapinn S.M., Zang Z. & Shahinfar S. (2001) Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. New England Journal of Medicine 345, 861-869.
10. Burt V.L., Cutler J.A., Higgins M., Horan M.J., Labarthe D., Whelton P., Brown C. & Roccella E.J. (1995) Trends in the prevalence, awareness, treatment and control of hypertension in the adult US population: data from the health examination surveys 1960 to 1991. Hypertension 26, 60-69.
11. Cabana M., Rand C., Powe N., Wu A.W., Wilson M.H., Abboud P.A. & Rubin H.R. (1999) Why don't physicians follow clinical practice guidelines? A framework for improvement. Journal of American Medical Association 282, 1458-1465.
12. Camisasca P., Avanzini F., Alli C., Colombo F. & Tognoni G. (2002) Overall cardiovascular risk still ignored in general practice care of hypertension. Journal of Cardiovascular Risk 9, 147-152.
13. Chamontin B., Poggi L., Lang M., Me'nard J., Chevalier H., Gallois H. & Cre'mier O. (1998) Prevalence, treatment and control of hypertension in the French population: data from a survey on high blood pressure in general practice 1994. American Journal of Hypertension 11, 759-762.
14. Colhoun H.M., Dong W. & Poulter N.R. (1998) Blood pressure screening, management and control in England: results from the health survey for England 1994. Journal of Hypertension 16, 747-752.
15. Cushman W.C. (2002) Hypertension control in clinical practice with a new standard in angiotensin II receptor blockade. American Journal of Hypertension 15, 99S-100S.
16. Daniels A., Biesma R., Otten J., Levitt N.S., Steyn K., Martell R. & Dick J. (2000) Ambivalence of primary health care professionals towards South African guidelines for hypertension and diabetes. South African Medical Journal 90, 1206-1211.
17. Domanski M., Mitchell G., Pfeiffer M., Neaton J.D., Norman J., Svendsen K., Grimm R., Cohen J. & Stamler J. (2002) Pulse pressure and cardiovascular disease related mortality. Journal of the American Medical Association 287, 2677-2683.
18. Epstein M. (2002) Recent landmark trials: how do they modify the therapeutic paradigm? American Journal of Hypertension 15, 825-845.
19. Estacio R.O. & Schrier R.W. (1998) Antihypertensive therapy in type 2 diabetes: implications of the Appropriate Blood Pressure Control in Diabetes (ABCD) trial. American Journal of Cardiology 82, 9R-14R.
20. Franklin S.S., Larson M.G., Khan S.A., Wong N.D., Leip E.P., Kannel W.B. & Levy D. (2001) Does the relation of blood pressure to coronary heart disease risk change with aging? Circulation 103, 1245-1249.
21. Grundy S.M., D'Augostino R.B., Mosca L., Burke G.L., Wilson P.W., Rader D.J., Cleeman J.I., Rochella E.J., Cutler J.A. & Freidman L.M. (2001) Cardiovascular risk assessment based on US Cohort studies: Findings from a National Heart, Lung and Blood Institute workshop. Circulation 104, 491-496.
22. Hansson L. (2002) Hypertension management in 2002: where have we been? Where might we be going? American Journal of Hypertension 15, 101S-107S.
23. Hansson L., Zanchetti A., Carruthers S.G., Dahlof B., Elmfeldt D., Julius S., Me'nard J., Rahn K.H., Wedel H. & Westerling S. (1998) Effect of intensive blood pressure lowering and low-dose aspirin in patients with hypertension. Principal results of the Hypertension Optimal Treatment (HOT) randomized trial. Lancet 351, 1755-1762.
24. Hyman D.J. & Pavlik V.N. (2000) Self-reported hypertension treatment practices among primary care physicians: blood pressure thresholds, drug choices, and the role of guidelines and evidence-based medicine. Archives of Internal Medicine 160, 2281-2286.
25. Hypertension Study Group. (2001) Prevalence, awareness, treatment and control of hypertension among the elderly in Bangladesh and India: a multicentre study. Bulletin of the World Health Organization 79, 490-500.
26. Ibrahim M.M., Rizk H., Appel L.J., Aroussy W., Helmy S., Sharaf Y., Ashour Z., Kandil H., Roccella E. & Whelton P.K. (1997) Hypertension surveys in the developing world: Lessons from the Egyptian National Hypertension Project (NHP). Journal of Human Hypertension 11, 709-726.
27. JNC-VI (Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure) (1997) The sixth report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Archives of Internal Medicine 157, 2413-2446.
28. Jo I., Ahn Y., Lee J., Shin K.R., Lee H.K. & Shin C. (2001) Prevalence, awareness, treatment, control and risk factors of hypertension in Korea: the Ansan study. Journal of Hypertension 19, 1523-1532.
29. Joffres M.R., Ghadirian P., Fodor J.G., Petrasovits A. & Chockalingam A. (1997) Awareness, treatment and control of hypertension in Canada. American Journal of Hypertension 10, 1097-1102.
30. Kastarinen M.J., Salomaa V.V., Vartiainen E.A., Jousilahti P.J., Tuomilehto J.O., Puska P.M. & Nissinen A.M. (1998) Trends in blood pressure levels and control of hypertension in Finland from 1982 to 1997. Journal of Hypertension 16, 1379-1387.
31. Katayama S., Inaba M., Morita T., Awata T., Shimamoto K. & Kikkawa R. (2000) Blood pressure control in Japanese hypertensives with or without type 2 diabetes mellitus. Hypertension Research 23, 601-605.
32. Laragh J.H. (2001) Treatment of hypertension is a worldwide failure. American Journal of Hypertension 14, 84-89.
33. Lenfant C. (2002) Reflection on hypertension control rates. A message from the director of the National Heart, Lung, and Blood Institute. Archives of Internal Medicine 162, 131-132.
34. Levine M. & Cosby J. (2002) Valuing knowledge and knowledge of values: understanding guideline-incongruent prescribing. Journal of Clinical Pharmacology 42, 475-476.
35. Lewis E.J. (2002) The role of angiotensin II receptor blockers in preventing the progression of renal disease in patients with type 2 diabetes. American Journal of Hypertension 15, 123S-128S.
36. Lexchin J. (1998) Improving the appropriateness of physician prescribing. International Journal of Health Services 28, 253-267.
37. Mancia G., Sega R., Milesi C., Cesana G. & Zanchetti A. (1997) Blood pressure control in the hypertensive population. Lancet 349, 454-457.
38. Mashru M. & Lant A. (1997) Interpractice audit of diagnosis and management of hypertension in primary care: educational intervention and review of medical records. British Medical Journal 314, 942-946.
39. Neutel J.M., Smith D.H. & Weber M. (2001) Low-dose combination therapy: an important first-line treatment in the management of hypertension. American Journal of Hypertension 14, 286-292.
40. Oliveria S.A., Lapuerta P., McCarthy B.D., L'Italien G.J., Berlowitz D.R. & Asch S.M. (2002) Physician related barriers to the effective management of uncontrolled hypertension. Archives of Internal Medicine 162, 413-420.
41. Olsen H., Klemenstrud T., Stokke H.P., Tretli S., Westheim A. (1999) Adverse drug reactions in current antihypertensive therapy: a general practice survey of 2586 patients in Norway. Blood Pressure 8, 94-101.
42. Oparil S. & Calhoun D.A. (1998) Managing the patient with hard-to-control hypertension. American Family Physician 57, 1007-1014, 1019-1020.
43. Padwal R., Straus S.E. & McAlister F.A. (2001) Cardiovascular risk factors and their impact on the decision to treat hypertension: an evidence based review. British Medical Journal 322, 977-980.
44. Paredes P., de la Pena M., Flores-Guerra E., Diaz J. & Trostle J. (1996) Factors influencing physicians' prescribing behaviour in the treatment of childhood diarrhea: knowledge may not be the clue. Social Science and Medicine 42, 1141-1153.
45. Przygoda P., Janson J., O'Flaherty M., Waisman G., Galarza C.R., Alfie J., Camera L.A., Camera M.J. & Mayorga L.M. (1998) Lack of effective blood pressure control among the elderly hypertensives in Buenos Aires. American Journal of Hypertension 11, 1024-1027.
46. Ramsay L.E., William B., Johnston C.D., MacGregor G.A., Poston L., Potter J.F., Poulter N.R. & Russel G. (1999) Guidelines for management of hypertension: report of the third working party of the British Hypertension Society. Journal of Human Hypertension 13, 569-592.
47. Tao S., Wu X., Duau X., Fang W., Hao J., Fau D., Wang W. & Li Y. (1995) Hypertension prevalence and status of awareness, treatment and control in China. Chinese Medical Journal 108, 483-489.
48. Thomson O'Brien M.A., Freemantle N., Oxman A.D., Wolf F., Davis D.A. & Herrin J. (2001) Continuing education meetings and workshops: effects on professional practice and health care outcomes. Cochrane Database Systematic Reviews 2, CD 003030, www.cochranelibrary.com.
49. UKPDS (UK Prospective Diabetes Study Group) (1998) Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes; UKPDS 38. British Medical Journal 317, 703-713.
50. Waeber B., Burnier M. & Brunner H.R. (2000) How to improve adherence with prescribed treatment in hypertensive patients? Journal of Cardiovascular Pharmacology 35 (Suppl.), S23-S26.
51. Weber M.A. (2002) Reducing cardiovascular and cerebral events (Editorial). American Journal of Hypertension 15, 75S-76S.
52. Westheim A., Klemetsrud T., Tretli S., Stokke H.P. & Olsen H. (2001) Blood pressure levels in treated hypertensive patients in general practice in Norway. Blood Pressure 10, 37-42.
53. WHO/ISH (World Health Organization/International Society of Hypertension) (1999) Guidelines for the management of hypertension. Journal of Hypertension 17, 151-183.
54. Worall G., Chaulk P. & Freake D. (1997) The effects of clinical practice guidelines on patient outcome in primary care: a systematic review. Journal of the Canadian Medical Association 156, 1705-1712.